Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 24 Sept 2026 for Ligand Pharmaceuticals INC, €30k. Read the official filing
Filing timeline
BuySaleMartine Zimmermann
Insider track record
Disclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Martine Zimmermann: trading record in brief
Martine Zimmermann discloses dealings in Ligand Pharmaceuticals Inc to SEC (Form 4). We count 6 filings; the first trade dates from 22 September 2023 and the latest from 22 September 2026.
Every open-market trade on record is a sale: 1 sale worth €294k. Outside the open market, there are 5 share grants. In 2026 alone, the filings show no purchases and 1 sale.
The newest entry dates from 24 September 2026: a share grant of €30k, in Ligand Pharmaceuticals Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Martine Zimmermann
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
115 shares@ US$298.50Common StockSEC:0002001011-26-000142:0
1,200 shares@ US$285.000.0060% mcap94.6% of flowCommon StockSEC:0002001011-26-000140:0
115 shares@ US$170.77100.0% of flowCommon StockSEC:0002001011-25-000081:0
1,209 shares0Common StockSEC:0002001011-25-000043:0
1,252 shares0Common StockSEC:0002001011-24-000060:0
2,285 shares0Common StockSEC:0000886163-23-000069:0
6 of 6 declarations
